Airway diseases
Respiratory critical care
Poster session
Bronchiectasis registries, cohorts and subgroups
Clinical
Methods :
Cell and molecular biology, Imaging, Pulmonary function testing, Pulmonary rehabilitation, Epidemiology, General respiratory patient care, Physiology, Public health
The microbiology of bronchiectasis in Europe: Data from the European Bronchiectasis Registry (EMBARC)
S. Aliberti(Milano (MI), Italy)
COI
1
The airway microbiome in Bronchiectasis-COPD overlap: data from the EMBARC-BRIDGE study
H. Keir(Dundee (Angus), United Kingdom)
COI
2
Inflammatory Endotypes, Microbiome and Exacerbation Risk in Bronchiectasis: A European Multicentre Study
A. Shoemark(Dundee (Angus), United Kingdom)
COI
3
The bronchiectasis exacerbation definition in a real-world setting: data from the EMBARC registry
M. Nigro(Milan, Italy)
COI
4
International validation of the Bronchiectasis Health Questionnaire (BHQ): data from the EMBARC-BRIDGE study
A. Spinou(London, United Kingdom)
COI
5
Alpha-1 antitrypsin deficiency genotypes in a large international cohort study of bronchiectasis (EMBARC BRIDGE)
F. Ringshausen(Hannover, Germany)
COI
6
Bronchiectasis in Patients with Chronic Lymphocytic Leukemia
O. Wand(Kfar Sava, Israel)
COI
7
Clinical phenotypes of bronchiectasis exacerbation: data from the EMBARC exacerbation substudy
M. Nigro(Milan, Italy)
COI
8
Bronchiectasis as a prognostic factor in patients with alpha 1 antitrypsin deficiency?
M. Dias Ferraz(Porto, Portugal)
COI
9
Alpha1antitrypsine (AAT) in sputum: is it a useful biomarker in Bronchiectasis (BE)?
L. Traversi(Cittiglio, Italy)
COI
10
A cohort series; referral bias and unmet needs in inflammatory bowel disease associated bronchiectasis
T. De Soyza(Newcastle-upon-Tyne, United Kingdom)
COI
11
Identification of a subgroup of non cystic fibrosis (CF) bronchiectasis patients with asthmatic traits
L. Carrozzi(Pisa (PI), Italy)
COI
12
A complete test panel avoids missed PCD diagnosis in adults with mild clinical phenotype
D. Calmés(Liège, Belgium)
COI
13
What are the radiological, microbiological and biochemical characteristics of bronchiectasis in alpha-1 antitrypsin deficiency? A systematic review
J. De Soyza(Birmingham, United Kingdom)
COI
14
Evaluation of the quality of life in patients followed for bronchial dilatation at the Hassan II Hospital in Agadir
K. Aitnasser(Agadir, Morocco)
COI
15
The Royal Brompton hospital adult primary ciliary dyskinesia (PCD) service: 2 years on
S. Peake(London, United Kingdom)
COI
16
Sputum colour assessment and clinical outcomes in bronchiectasis: data from the EMBARC Registry
M. Crichton(Dundee (Angus), United Kingdom)
COI
17
Mannitol vs Hypertonic saline in non-CF bronchiectasis, a systematic review, pairwise, and network meta-analysis of randomized control trials.
M. H. Fathy(New Cairo, Egypt)
COI
18
Bronchiectasis associated to connective tissue diseases: a single-center experience
A. Stainer(Vigevano, Italy)
COI
19
Phenotypes in adult patients with bronchiectasis: a cluster analysis
O. Munteanu(Chișinău (Chișinău), Republic of Moldova)
COI
20
. . .
